5-Fluorouracil in primary, impending recurrent and recurrent pterygium: Systematic review of the efficacy and safety of a surgical adjuvant and intralesional …
BWH Lee, AS Sidhu, IC Francis, MT Coroneo - The Ocular Surface, 2022 - Elsevier
Pterygium is an ultraviolet-related disease characterized by an aberrant, wing-shaped and
active wound-healing process. There is nothing quite as disheartening for the surgeon or …
active wound-healing process. There is nothing quite as disheartening for the surgeon or …
[HTML][HTML] Efficacy of 5-Fluorouracil in the Treatment of Pterygium
SU Shah, T Ahmed, A Badar, M Shafique, S Malik… - Cureus, 2021 - ncbi.nlm.nih.gov
Results In our study the mean age of the patients was 37.74±10.15 years, male to female
ratio of the patients was 1.06: 1. The primary type of pterygium was noted in 54 (53.5%) and …
ratio of the patients was 1.06: 1. The primary type of pterygium was noted in 54 (53.5%) and …
Pterygium recurrence following preoperative topical Mitomycin C and 5-Fluorouracil eyedrops
J Rajagopal, GK Das, S Sharma, PK Sahu - Journal Français d' …, 2024 - Elsevier
Introduction Various adjuvant therapies have been used to prevent recurrence after
pterygium excision. However, no single agent has been proven to be a gold standard for …
pterygium excision. However, no single agent has been proven to be a gold standard for …
Sub-conjunctival injection of 5 Fluorouracilversus Bevacizumab in Treatment of Primary Pterygium
S Parveen, S Naeem, W Muzaffar, MK Saeed - Pakistan Journal of …, 2023 - pjo.org.pk
Purpose: To compare effectiveness and safety of 5 Fluorouracil versus Bevacizumab as sole
therapy in the treatment of primary pterygium. Study Design: Quasi-experimental study …
therapy in the treatment of primary pterygium. Study Design: Quasi-experimental study …